InvestorsHub Logo
Followers 646
Posts 144549
Boards Moderated 1
Alias Born 05/19/2007

Re: None

Friday, 03/23/2018 11:24:21 AM

Friday, March 23, 2018 11:24:21 AM

Post# of 54890
$PMCB's Institutional Stock Ownership and Shareholders

Pharmacyte Biotech has 4 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,054,073 shares. Largest shareholders include Panagora Asset Management Inc, Fisher Asset Management, LLC, Adell Harriman & Carpenter Inc, and Moloney Securities Asset Management, LLC.

PharmaCyte Biotech ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. https://fintel.io/so/us/pmcb

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.